Orna Therapeutics
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
620 Memorial Dr Fl 2, Cambridge, Massach...Phone Number
(617) 977-6357Website
www.ornatx.comRevenue
$41.2 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
4
3
1
1
2
About Orna Therapeutics
Headquartered in Cambridge, Massachusetts, Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way diseases are treated.Explore more
Orna Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orna Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Orna Therapeutics launches new products
Earning: See what the market has to say on Orna Therapeutics recently announced quarterly report
Check out if Orna Therapeutics is spiking on competitors!
Orna Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Orna Therapeutics
Funding: Get notified immidiatlly once Orna Therapeutics has new funding data
Check if Orna Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Orna Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Orna Therapeutics
Find 2 more new buyers
Compare Similar Companies to Orna Therapeutics
Compare insights from companies similar to Orna Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
$56.1M
2021
Company Profile Activity
Activity Insights
Orna Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Orna Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Orna Therapeutics.
Orna Therapeutics financials insights
Gather financial insights about Orna Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$80M
2022
Series B
$221M
Orna Therapeutics Tech Stack
A closer look at the technologies used by Orna Therapeutics
Most Recent Scoops
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Open Position
Hiring Plans
Hiring Plans
Orna Therapeutics News & Media
Lilly to acquire Orna Therapeutics to advance cell therapies
Orna's in vivo CAR-T pipeline includes potential best-in-class programs to reset the immune system and address B cell-driven autoimmune diseases Acquisition provides a broad platform for long-term innovation in genetic medicine and in vivo cell engineering INDIANAPOLIS and WATERTOWN, Mass....Orna Therapeutics Announces Multiple Presentations Supporting its in vivo CAR Programs for Autoimmune Diseases at the 67th American Society of Hematology Annual Meeting
WATERTOWN, Mass., Nov. 3, 2025 /PRNewswire/ -- Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat autoimmune and oncology diseases, today announced upcoming presentations at the 67th American Society of Hematology (ASH) Annual Meeting being...Orna Therapeutics Announces Encore Presentation at the American College of Rheumatology Annual Meeting Supporting its in vivo CAR Therapy Approach in Autoimmune Diseases
WATERTOWN, Mass., Oct. 24, 2025 /PRNewswire/ -- Orna Therapeutics, a leading biotechnology company developing a proprietary pipeline of in vivo therapies across a broad range of autoimmune and oncology indications, today announced an upcoming presentation at the American College of...Orna Therapeutics Presents New Preclinical Data Supporting its in vivo CAR Therapy Approach in Autoimmune Diseases at the American Society of Gene and Cell Therapy Annual Meeting
WATERTOWN, Mass., May 15, 2025 /PRNewswire/ -- Orna Therapeutics, a leading biotechnology company developing a proprietary pipeline of in vivo therapies across a broad range of autoimmune and oncology indications, today announced the presentation of new preclinical data supporting its in...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Orna Therapeutics
Sign Up For FreeTo access detailed company insights
Headquartered in Cambridge, Massachusetts, Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way diseases are treated.... Read More
